Nurse Practitioner in North Myrtle Beach, SC Accepting Medicare

26 Nurse Practitioner nurses found. Showing 21 - 26

Erik L Herte, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1010 Highway 17 N, North Myrtle Beach, SC 29582 Phone: 843-249-1451

Shari L Clarke, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1010 Highway 17 N, North Myrtle Beach, SC 29582 Phone: 843-249-1451

Kayla Marie Sobotka, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1010 Highway 17 N, North Myrtle Beach, SC 29582 Phone: 843-249-1451

Savannah Thames, APRN, PMHNP Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 1016 2nd Ave N Ste 205, North Myrtle Beach, SC 29582 Phone: 843-491-3344

Doris June O'kelley, C.R.N.P. Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1010 Highway 17 N, North Myrtle Beach, SC 29582 Phone: 256-627-9547

Krista Michelle Poulton, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1010 Highway 17 N, North Myrtle Beach, SC 29582 Phone: 866-389-2727

News Archive

Health IT Now! Coalition panel discussion: Develop affordable access to broadband and healthcare

The Health IT Now! Coalition hosted a panel discussion today with the Federal Communications Commission and a panel of experts to discuss the FCC's National Broadband Plan and its proposals to develop affordable access to broadband and healthcare.

Cancer treatment may undergo a paradigm shift to immunotherapy soon

Immunotherapy when used for cancer treatment could extend life longer finds studies. Experts have explained that until now immunotherapy was reserved as a last resort for most patients and treatment usually comprised of chemotherapy and radiation therapy failing which these were tried. In a pair of clinical trials, researchers have found that using immunotherapy as first line treatment can extend lives of these cancer patients.

Researchers use single cell sequencing technology to characterize immune system of COVID-19 patients

In this study, which was published in the journal Frontiers in Immunology on September 30th, researchers used sequencing to characterize the immune system of patients who survive from COVID-19 infection from symptom onset through recovery.

GlaxoSmithKline to pursue novel antibacterial research program for DOD

GlaxoSmithKline has announced that it has signed an agreement with the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DOD), to identify and develop a new class of antibacterials targeting both Gram negative biothreats and conventional Gram negative hospital pathogens.

Read more Medical News

› Verified 8 days ago

• 1
• 2(current)